ConductScience.org, home

Paper533258

Bronchial secretion levels of amikacin.

Dull WL and 2 others. Antimicrob Agents Chemother, 1979. Cited by 39 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Bronchial secretion levels of amikacin. Papers, record 533258. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/533258

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bronchial secretion levels of amikacin.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
39
iCite
Relative citation ratio, by iCite
2.03
iCite
Revised in PubMed
2021-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dull WLW L
2Alexander MRM R
3Kasik JEJ E

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmikacinMajor topic
BronchiMajor topic
KanamycinMajor topic
Aged
Half-Life
Humans
Male
Middle Aged
Time Factors

Source PubMed

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,157,342Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4157342PubMed
2374,019The concentration of tobramycin in bronchial secretions.Chest1979https://conductscience.org/library/papers/374019PubMed
3374,017Endotracheally administered antibiotics for gram-negative bronchopneumonia.Chest1979https://conductscience.org/library/papers/374017PubMed
4319,355Controlled comparison of amikacin and gentamicin.N Engl J Med1977https://conductscience.org/library/papers/319355PubMed
5279,981Pharmacokinetic study of beta-lactam antibiotics in bronchial secretions.Scand J Infect Dis Suppl1978https://conductscience.org/library/papers/279981PubMed
6730,392[Tobramycin Concentration in Human Lung Tissue (author's transl)].Infection1978https://conductscience.org/library/papers/730392PubMed
7868,912Amikacin in the treatment of gram-negative pneumonia.Am J Med1977https://conductscience.org/library/papers/868912PubMed
8868,911Amikacin treatment of pulmonary infections involving gentamicin-resistant gram-negative bacilli.Am J Med1977https://conductscience.org/library/papers/868911PubMed
9864,291Penetration of tobramycin into infected extravascular fluids and its therapeutic effectiveness.J Infect Dis1977https://conductscience.org/library/papers/864291PubMed
10825,588Susceptibility of recently isolated bacteria to amikacin in vitro: comparisons with four other aminoglycoside antibiotics.J Infect Dis1976https://conductscience.org/library/papers/825588PubMed
11977,997Synergism between amikacin and cefazolin against Klebsiella: in vitro studies and effect on the bactericidal activity of serum.J Infect Dis1976https://conductscience.org/library/papers/977997PubMed
124,146,250Concentrations of gentamicin and carbenicillin in bronchial secretions.J Infect Dis1973https://conductscience.org/library/papers/4146250PubMed
13168,036Diagnostic fiberoptic bronchoscopy: Techniques and results of biopsy in 600 patients.Chest1975https://conductscience.org/library/papers/168036PubMed
144,318,047Ampicillin levels in sputum, serum, and saliva.Thorax1970https://conductscience.org/library/papers/4318047PubMed
154,210,297Comparative pharmacokinetics of amikacin and kanamycin.Clin Pharmacol Ther1974https://conductscience.org/library/papers/4210297PubMed
164,790,621Cephalexin concentrations in sputum during acute respiratory infections.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4790621PubMed
175,000,612Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections.J Pediatr1971https://conductscience.org/library/papers/5000612PubMed
18807,603Concentrations of gentamicin in bronchial secretions after intramuscular and endotracheal administration.J Clin Pharmacol1975https://conductscience.org/library/papers/807603PubMed
191,200,524Amikacin therapy for serious gram-negative bacillary infections.Ann Intern Med1975https://conductscience.org/library/papers/1200524PubMed
201,155,479Penetration of antimicrobial agents into bronchial secretions.Am J Med1975https://conductscience.org/library/papers/1155479PubMed

See all 23 references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMIDTitleJournalYearIn PapersSource
27,458,224Artificial Intelligence and Amikacin Exposures Predictive of Outcomes in Multidrug-Resistant Tuberculosis Patients.Antimicrob Agents Chemother2016https://conductscience.org/library/papers/27458224PubMed
27,458,221Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection.Antimicrob Agents Chemother2016https://conductscience.org/library/papers/27458221PubMed
27,458,215Amikacin Optimal Exposure Targets in the Hollow-Fiber System Model of Tuberculosis.Antimicrob Agents Chemother2016https://conductscience.org/library/papers/27458215PubMed
26,643,339Amikacin Pharmacokinetics/Pharmacodynamics in a Novel Hollow-Fiber Mycobacterium abscessus Disease Model.Antimicrob Agents Chemother2015https://conductscience.org/library/papers/26643339PubMed
21,709,076Quantification of amikacin in bronchial epithelial lining fluid in neonates.Antimicrob Agents Chemother2011https://conductscience.org/library/papers/21709076PubMed
15,536,528Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness.Intensive Care Med2004https://conductscience.org/library/papers/15536528PubMed
8,882,302Drug monitoring in nonconventional biological fluids and matrices.Clin Pharmacokinet1996https://conductscience.org/library/papers/8882302PubMed
7,695,320Amikacin levels in bronchial secretions of 10 pneumonia patients with respiratory support treated once daily versus twice daily.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/7695320PubMed
6,810,757Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6810757PubMed
3,606,080Penetration of cefotaxime into respiratory secretions.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3606080PubMed
2,692,939Clinical pharmacokinetics in infants and children. A reappraisal.Clin Pharmacokinet1989https://conductscience.org/library/papers/2692939PubMed
1,724,642Drug treatment of pneumonia in the hospital. What are the choices?Drugs1991https://conductscience.org/library/papers/1724642PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/533258

GET https://conductscience.org/api/papers/v1/533258/references?page=2